New antibacterial agents are urgently needed to address the global increase in resistance. In this Review, Theuretzbacher and colleagues critically review the current published literature and publicly available information on antibacterial agents in all phases of clinical development.
- Ursula Theuretzbacher
- Karen Bush
- Guy E. Thwaites